Living

UniQure gets FDA green light to file for Huntington's gene therapy approval

By Reuters Reuters
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo
FILE PHOTO: Signage is seen outside of the Food and Drug Administration (FDA) headquarters in White Oak, Maryland, U.S., August 29, 2020. REUTERS/Andrew Kelly/File Photo ANDREW KELLY Reuters

Dutch drugmaker UniQure said on Wednesday the U.S. Food and Drug Administration has agreed that data from a mid-stage study could support an accelerated approval filing for its gene therapy to treat Huntington's disease.

(Reporting by Kamal Choudhury in Bengaluru; Editing by Jonathan Ananda)

Copyright Reuters or USA Today Network via Reuters Connect

This story was originally published June 17, 2026 at 4:11 AM.

Get one year of unlimited digital access for $159.99
#ReadLocal

Only 44¢ per day

SUBSCRIBE NOW